The Potassium Chloride Extended-Rele, cataloged under National Stock Number 6505-01-266-8634, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Andrx Pharmaceuticals Inc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 10 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-266-8634 |
| Primary Part Number | NDC62037-0720-01 |
| Item Name | Potassium Chloride Extended-Rele |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Andrx Pharmaceuticals Inc |
| Status | ACTIVE |
| Therapeutic Equivalent | K-DUR BY KEY PHARMACEUTICALS |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | UNIT DOSE |
| Primary Container Type | STRIP |
| Active Medicament Medicinal Strength | 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC62037-0720-01 PRIMARY | Andrx Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC59930-1714-01 | 5/1 Secondary reference Warrick Pharmaceuticals Inc |
| NDC00093-5311-01 | 5/1 Secondary reference U.S. Government activity |
| NDC58177-0202-04 | 5/1 Secondary reference Ethex Corp Sub of K-V Pharmaceutical Co |
| K-DUR | 5/9 Secondary reference Schering-Plough Corporation |
| NDC00245-0058-11 | 5/1 Secondary reference Upsher-Smith Laboratories, Llc |
| NDC00085-0787-01 | 5/9 Secondary reference Schering-Plough Corporation |
| NDC00085-0787-81 | 5/9 Secondary reference Schering-Plough Corporation |
| NDC00245-0058-01 | 5/1 Secondary reference Upsher-Smith Laboratories, Llc |
| NDC58177-0202-11 | 5/1 Secondary reference Ethex Corp Sub of K-V Pharmaceutical Co |
| K-DUR TABLETS | 5/9 Secondary reference Schering-Plough Corporation |
NSN 6505-01-266-8634 is a Potassium Chloride Extended-Rele, manufactured by Andrx Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-266-8634 has 1 manufacturer part number on file: NDC62037-0720-01 (Andrx Pharmaceuticals Inc).
Key specifications for NDC62037-0720-01: Therapeutic Equivalent: K-DUR BY KEY PHARMACEUTICALS; Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: UNIT DOSE. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.